HIV, adolescents, cabotegravir and rilpivirine, antiretroviral therapy, injectable, clinical trial
HIV, adolescents, dolutegravir, short cycle therapy, young people, randomised controlled trial
Children, adolescents, HIV, dolutegravir, neuropsychiatric, adverse events, mood problems, sleep problems, randomised controlled trial